Standout Papers

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experien... 2007 2026 2013 2019 436
  1. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial (2007)
    Beatriz Grinsztejn, Bach-Yen Nguyen et al. The Lancet

Immediate Impact

10 from Science/Nature 78 standout
Sub-graph 1 of 18

Citing Papers

AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
2024 Standout
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
35 intermediate papers

Works of Joshua Chen being referenced

Accuracy of multiecho magnitude‐based MRI (M‐MRI) for estimation of hepatic proton density fat fraction (PDFF) in children
2015
Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial
2012

Author Peers

Author Last Decade Papers Cites
Joshua Chen 450 114 63 580 519 26 1.2k
Robert H. Kauffmann 468 136 14 578 352 33 1.7k
Sudhir Penugonda 445 110 18 625 710 37 1.6k
Julia Harris 185 90 10 349 274 19 1.5k
James Goodrich 528 99 19 1069 1077 31 1.7k
H Jablonowski 455 203 34 351 202 61 1.3k
Julie Galimand 262 20 44 601 535 26 1.2k
Marilia Rita Pinzone 365 68 74 409 346 52 1.4k
Vincent Aubert 244 164 19 400 287 74 1.1k
John W. Heitman 387 48 29 416 609 37 1.7k
Patricia Cane 390 83 19 518 397 26 1.0k

All Works

Loading papers...

Rankless by CCL
2026